Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents

HIV-1 vertically infected children in the USA are living into adolescence and beyond with the widespread use of antiretroviral drugs. These patients exhibit striking differences in the rate of HIV-1 disease progression which could provide insights into mechanisms of control. We hypothesized that dif...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2011-07, Vol.6 (7), p.e21135-e21135
Hauptverfasser: Sharp, Elizabeth R, Willberg, Christian B, Kuebler, Peter J, Abadi, Jacob, Fennelly, Glenn J, Dobroszycki, Joanna, Wiznia, Andrew A, Rosenberg, Michael G, Nixon, Douglas F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e21135
container_issue 7
container_start_page e21135
container_title PloS one
container_volume 6
creator Sharp, Elizabeth R
Willberg, Christian B
Kuebler, Peter J
Abadi, Jacob
Fennelly, Glenn J
Dobroszycki, Joanna
Wiznia, Andrew A
Rosenberg, Michael G
Nixon, Douglas F
description HIV-1 vertically infected children in the USA are living into adolescence and beyond with the widespread use of antiretroviral drugs. These patients exhibit striking differences in the rate of HIV-1 disease progression which could provide insights into mechanisms of control. We hypothesized that differences in the pattern of immunodomination including breadth, magnitude and polyfunctionality of HIV-1 specific CD8+ T cell response could partially explain differences in progression rate. In this study, we mapped, quantified, and assessed the functionality of these responses against individual HIV-1 Gag peptides in 58 HIV-1 vertically infected adolescents. Subjects were divided into two groups depending upon the rate of disease progression: adolescents with a sustained CD4%≥25 were categorized as having no immune suppression (NS), and those with CD4%≤15 categorized as having severe immune suppression (SS). We observed differences in the area of HIV-1-Gag to which the two groups made responses. In addition, subjects who expressed the HLA- B*57 or B*42 alleles were highly likely to restrict their immunodominant response through these alleles. There was a significantly higher frequency of naïve CD8+ T cells in the NS subjects (p = 0.0066) compared to the SS subjects. In contrast, there were no statistically significant differences in any other CD8+ T cell subsets. The differentiation profiles and multifunctionality of Gag-specific CD8+ T cells, regardless of immunodominance, also failed to demonstrate meaningful differences between the two groups. Together, these data suggest that, at least in vertically infected adolescents, the region of HIV-1-Gag targeted by CD8+ T cells and the magnitude of that response relative to other responses may have more importance on the rate of disease progression than their qualitative effector functions.
doi_str_mv 10.1371/journal.pone.0021135
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1306361280</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A476884446</galeid><doaj_id>oai_doaj_org_article_678fe0ce20704414b5075c0545e92013</doaj_id><sourcerecordid>A476884446</sourcerecordid><originalsourceid>FETCH-LOGICAL-c691t-c918bcd53c9cf6cf1c38ba4ef6f20130cf8ff7e4f9d9520a287fe3a6436efdd03</originalsourceid><addsrcrecordid>eNqNk1tv0zAUxyMEYmPwDRBYQgIh1GLHlzgvSFO5rNKkSTD2arnOcevKibs4mdgj3xyHZlOD9oDy4Nj-_c_VJ8teEjwntCAft6FvG-3nu9DAHOOcEMofZcekpPlM5Jg-Pvg_yp7FuMWYUynE0-woJ5LInPPj7PeyrvsmVKF2jW4MoGDR2fJqRlDcgXHWGbT4LD-gy5kB71ELMfmLEJGLaeN1BxXqAqpcBB0B7dqwTkx0oUFtukSuQTfQds5o72_TzoIZJLoKHqKBpovPsydW-wgvxvUk-_n1y-XibHZ-8W25OD2fGVGSbmZKIlem4tSUxgpjiaFypRlYYXNMKDZWWlsAs2VV8hzrXBYWqBaMCrBVhelJ9npvd-dDVGP1okpSQQXJ5UAs90QV9FbtWlfr9lYF7dTfg9CulR5S8aBEIS1gAzkuMGOErTguuMGccSiHcJKtT6O3flVDNWTaaj8xOr1p3Eatw42ihJa8GIJ5Nxpow3UPsVO1i0MPdAOhj0pKwkRRSJ7IN_-QDyc3Umud4k-NCMmtGWyqU1YIKRljIlHzB6j0VVA7k16adel8Ing_ESSmg1_dWvcxquWP7__PXlxN2bcH7Aa07zYx-L5LLytOQbYHTRtibMHe15hgNQzKXTXUMChqHJQke3XYn3vR3WTQP9yXDoM</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1306361280</pqid></control><display><type>article</type><title>Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents</title><source>Public Library of Science (PLoS) Journals Open Access</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Sharp, Elizabeth R ; Willberg, Christian B ; Kuebler, Peter J ; Abadi, Jacob ; Fennelly, Glenn J ; Dobroszycki, Joanna ; Wiznia, Andrew A ; Rosenberg, Michael G ; Nixon, Douglas F</creator><creatorcontrib>Sharp, Elizabeth R ; Willberg, Christian B ; Kuebler, Peter J ; Abadi, Jacob ; Fennelly, Glenn J ; Dobroszycki, Joanna ; Wiznia, Andrew A ; Rosenberg, Michael G ; Nixon, Douglas F</creatorcontrib><description>HIV-1 vertically infected children in the USA are living into adolescence and beyond with the widespread use of antiretroviral drugs. These patients exhibit striking differences in the rate of HIV-1 disease progression which could provide insights into mechanisms of control. We hypothesized that differences in the pattern of immunodomination including breadth, magnitude and polyfunctionality of HIV-1 specific CD8+ T cell response could partially explain differences in progression rate. In this study, we mapped, quantified, and assessed the functionality of these responses against individual HIV-1 Gag peptides in 58 HIV-1 vertically infected adolescents. Subjects were divided into two groups depending upon the rate of disease progression: adolescents with a sustained CD4%≥25 were categorized as having no immune suppression (NS), and those with CD4%≤15 categorized as having severe immune suppression (SS). We observed differences in the area of HIV-1-Gag to which the two groups made responses. In addition, subjects who expressed the HLA- B*57 or B*42 alleles were highly likely to restrict their immunodominant response through these alleles. There was a significantly higher frequency of naïve CD8+ T cells in the NS subjects (p = 0.0066) compared to the SS subjects. In contrast, there were no statistically significant differences in any other CD8+ T cell subsets. The differentiation profiles and multifunctionality of Gag-specific CD8+ T cells, regardless of immunodominance, also failed to demonstrate meaningful differences between the two groups. Together, these data suggest that, at least in vertically infected adolescents, the region of HIV-1-Gag targeted by CD8+ T cells and the magnitude of that response relative to other responses may have more importance on the rate of disease progression than their qualitative effector functions.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0021135</identifier><identifier>PMID: 21818255</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acquired immune deficiency syndrome ; Adolescent ; Adolescents ; AIDS ; Alleles ; Amino Acid Sequence ; Antiretroviral agents ; Biology ; CD4 antigen ; CD8 antigen ; CD8-Positive T-Lymphocytes - immunology ; CD8-Positive T-Lymphocytes - pathology ; CD8-Positive T-Lymphocytes - physiology ; Cell Degranulation ; Cell Differentiation - immunology ; Children ; Cohort Studies ; Cytokines - metabolism ; Development and progression ; Disease control ; Disease Progression ; Drugs ; Female ; gag Gene Products, Human Immunodeficiency Virus - immunology ; Highly active antiretroviral therapy ; Histocompatibility antigen HLA ; HIV ; HIV Infections - immunology ; HIV Infections - virology ; HIV-1 - immunology ; HLA antigens ; HLA Antigens - immunology ; Human immunodeficiency virus ; Humans ; Immunodominance ; Immunodominant Epitopes - immunology ; Immunosuppressive agents ; Infectious Disease Transmission, Vertical ; Lymphocytes ; Lymphocytes T ; Male ; Medicine ; Molecular Sequence Data ; Pediatric diseases ; Peptides ; Peptides - chemistry ; Peptides - immunology ; Species Specificity ; Statistical analysis ; T cell receptors ; T cells ; Teenagers ; Vaccines ; Youth</subject><ispartof>PloS one, 2011-07, Vol.6 (7), p.e21135-e21135</ispartof><rights>COPYRIGHT 2011 Public Library of Science</rights><rights>2011 Sharp et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Sharp et al. 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c691t-c918bcd53c9cf6cf1c38ba4ef6f20130cf8ff7e4f9d9520a287fe3a6436efdd03</citedby><cites>FETCH-LOGICAL-c691t-c918bcd53c9cf6cf1c38ba4ef6f20130cf8ff7e4f9d9520a287fe3a6436efdd03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139570/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139570/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21818255$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sharp, Elizabeth R</creatorcontrib><creatorcontrib>Willberg, Christian B</creatorcontrib><creatorcontrib>Kuebler, Peter J</creatorcontrib><creatorcontrib>Abadi, Jacob</creatorcontrib><creatorcontrib>Fennelly, Glenn J</creatorcontrib><creatorcontrib>Dobroszycki, Joanna</creatorcontrib><creatorcontrib>Wiznia, Andrew A</creatorcontrib><creatorcontrib>Rosenberg, Michael G</creatorcontrib><creatorcontrib>Nixon, Douglas F</creatorcontrib><title>Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>HIV-1 vertically infected children in the USA are living into adolescence and beyond with the widespread use of antiretroviral drugs. These patients exhibit striking differences in the rate of HIV-1 disease progression which could provide insights into mechanisms of control. We hypothesized that differences in the pattern of immunodomination including breadth, magnitude and polyfunctionality of HIV-1 specific CD8+ T cell response could partially explain differences in progression rate. In this study, we mapped, quantified, and assessed the functionality of these responses against individual HIV-1 Gag peptides in 58 HIV-1 vertically infected adolescents. Subjects were divided into two groups depending upon the rate of disease progression: adolescents with a sustained CD4%≥25 were categorized as having no immune suppression (NS), and those with CD4%≤15 categorized as having severe immune suppression (SS). We observed differences in the area of HIV-1-Gag to which the two groups made responses. In addition, subjects who expressed the HLA- B*57 or B*42 alleles were highly likely to restrict their immunodominant response through these alleles. There was a significantly higher frequency of naïve CD8+ T cells in the NS subjects (p = 0.0066) compared to the SS subjects. In contrast, there were no statistically significant differences in any other CD8+ T cell subsets. The differentiation profiles and multifunctionality of Gag-specific CD8+ T cells, regardless of immunodominance, also failed to demonstrate meaningful differences between the two groups. Together, these data suggest that, at least in vertically infected adolescents, the region of HIV-1-Gag targeted by CD8+ T cells and the magnitude of that response relative to other responses may have more importance on the rate of disease progression than their qualitative effector functions.</description><subject>Acquired immune deficiency syndrome</subject><subject>Adolescent</subject><subject>Adolescents</subject><subject>AIDS</subject><subject>Alleles</subject><subject>Amino Acid Sequence</subject><subject>Antiretroviral agents</subject><subject>Biology</subject><subject>CD4 antigen</subject><subject>CD8 antigen</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>CD8-Positive T-Lymphocytes - pathology</subject><subject>CD8-Positive T-Lymphocytes - physiology</subject><subject>Cell Degranulation</subject><subject>Cell Differentiation - immunology</subject><subject>Children</subject><subject>Cohort Studies</subject><subject>Cytokines - metabolism</subject><subject>Development and progression</subject><subject>Disease control</subject><subject>Disease Progression</subject><subject>Drugs</subject><subject>Female</subject><subject>gag Gene Products, Human Immunodeficiency Virus - immunology</subject><subject>Highly active antiretroviral therapy</subject><subject>Histocompatibility antigen HLA</subject><subject>HIV</subject><subject>HIV Infections - immunology</subject><subject>HIV Infections - virology</subject><subject>HIV-1 - immunology</subject><subject>HLA antigens</subject><subject>HLA Antigens - immunology</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Immunodominance</subject><subject>Immunodominant Epitopes - immunology</subject><subject>Immunosuppressive agents</subject><subject>Infectious Disease Transmission, Vertical</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Male</subject><subject>Medicine</subject><subject>Molecular Sequence Data</subject><subject>Pediatric diseases</subject><subject>Peptides</subject><subject>Peptides - chemistry</subject><subject>Peptides - immunology</subject><subject>Species Specificity</subject><subject>Statistical analysis</subject><subject>T cell receptors</subject><subject>T cells</subject><subject>Teenagers</subject><subject>Vaccines</subject><subject>Youth</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk1tv0zAUxyMEYmPwDRBYQgIh1GLHlzgvSFO5rNKkSTD2arnOcevKibs4mdgj3xyHZlOD9oDy4Nj-_c_VJ8teEjwntCAft6FvG-3nu9DAHOOcEMofZcekpPlM5Jg-Pvg_yp7FuMWYUynE0-woJ5LInPPj7PeyrvsmVKF2jW4MoGDR2fJqRlDcgXHWGbT4LD-gy5kB71ELMfmLEJGLaeN1BxXqAqpcBB0B7dqwTkx0oUFtukSuQTfQds5o72_TzoIZJLoKHqKBpovPsydW-wgvxvUk-_n1y-XibHZ-8W25OD2fGVGSbmZKIlem4tSUxgpjiaFypRlYYXNMKDZWWlsAs2VV8hzrXBYWqBaMCrBVhelJ9npvd-dDVGP1okpSQQXJ5UAs90QV9FbtWlfr9lYF7dTfg9CulR5S8aBEIS1gAzkuMGOErTguuMGccSiHcJKtT6O3flVDNWTaaj8xOr1p3Eatw42ihJa8GIJ5Nxpow3UPsVO1i0MPdAOhj0pKwkRRSJ7IN_-QDyc3Umud4k-NCMmtGWyqU1YIKRljIlHzB6j0VVA7k16adel8Ing_ESSmg1_dWvcxquWP7__PXlxN2bcH7Aa07zYx-L5LLytOQbYHTRtibMHe15hgNQzKXTXUMChqHJQke3XYn3vR3WTQP9yXDoM</recordid><startdate>20110719</startdate><enddate>20110719</enddate><creator>Sharp, Elizabeth R</creator><creator>Willberg, Christian B</creator><creator>Kuebler, Peter J</creator><creator>Abadi, Jacob</creator><creator>Fennelly, Glenn J</creator><creator>Dobroszycki, Joanna</creator><creator>Wiznia, Andrew A</creator><creator>Rosenberg, Michael G</creator><creator>Nixon, Douglas F</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20110719</creationdate><title>Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents</title><author>Sharp, Elizabeth R ; Willberg, Christian B ; Kuebler, Peter J ; Abadi, Jacob ; Fennelly, Glenn J ; Dobroszycki, Joanna ; Wiznia, Andrew A ; Rosenberg, Michael G ; Nixon, Douglas F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c691t-c918bcd53c9cf6cf1c38ba4ef6f20130cf8ff7e4f9d9520a287fe3a6436efdd03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Adolescent</topic><topic>Adolescents</topic><topic>AIDS</topic><topic>Alleles</topic><topic>Amino Acid Sequence</topic><topic>Antiretroviral agents</topic><topic>Biology</topic><topic>CD4 antigen</topic><topic>CD8 antigen</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>CD8-Positive T-Lymphocytes - pathology</topic><topic>CD8-Positive T-Lymphocytes - physiology</topic><topic>Cell Degranulation</topic><topic>Cell Differentiation - immunology</topic><topic>Children</topic><topic>Cohort Studies</topic><topic>Cytokines - metabolism</topic><topic>Development and progression</topic><topic>Disease control</topic><topic>Disease Progression</topic><topic>Drugs</topic><topic>Female</topic><topic>gag Gene Products, Human Immunodeficiency Virus - immunology</topic><topic>Highly active antiretroviral therapy</topic><topic>Histocompatibility antigen HLA</topic><topic>HIV</topic><topic>HIV Infections - immunology</topic><topic>HIV Infections - virology</topic><topic>HIV-1 - immunology</topic><topic>HLA antigens</topic><topic>HLA Antigens - immunology</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Immunodominance</topic><topic>Immunodominant Epitopes - immunology</topic><topic>Immunosuppressive agents</topic><topic>Infectious Disease Transmission, Vertical</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Male</topic><topic>Medicine</topic><topic>Molecular Sequence Data</topic><topic>Pediatric diseases</topic><topic>Peptides</topic><topic>Peptides - chemistry</topic><topic>Peptides - immunology</topic><topic>Species Specificity</topic><topic>Statistical analysis</topic><topic>T cell receptors</topic><topic>T cells</topic><topic>Teenagers</topic><topic>Vaccines</topic><topic>Youth</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sharp, Elizabeth R</creatorcontrib><creatorcontrib>Willberg, Christian B</creatorcontrib><creatorcontrib>Kuebler, Peter J</creatorcontrib><creatorcontrib>Abadi, Jacob</creatorcontrib><creatorcontrib>Fennelly, Glenn J</creatorcontrib><creatorcontrib>Dobroszycki, Joanna</creatorcontrib><creatorcontrib>Wiznia, Andrew A</creatorcontrib><creatorcontrib>Rosenberg, Michael G</creatorcontrib><creatorcontrib>Nixon, Douglas F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sharp, Elizabeth R</au><au>Willberg, Christian B</au><au>Kuebler, Peter J</au><au>Abadi, Jacob</au><au>Fennelly, Glenn J</au><au>Dobroszycki, Joanna</au><au>Wiznia, Andrew A</au><au>Rosenberg, Michael G</au><au>Nixon, Douglas F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2011-07-19</date><risdate>2011</risdate><volume>6</volume><issue>7</issue><spage>e21135</spage><epage>e21135</epage><pages>e21135-e21135</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>HIV-1 vertically infected children in the USA are living into adolescence and beyond with the widespread use of antiretroviral drugs. These patients exhibit striking differences in the rate of HIV-1 disease progression which could provide insights into mechanisms of control. We hypothesized that differences in the pattern of immunodomination including breadth, magnitude and polyfunctionality of HIV-1 specific CD8+ T cell response could partially explain differences in progression rate. In this study, we mapped, quantified, and assessed the functionality of these responses against individual HIV-1 Gag peptides in 58 HIV-1 vertically infected adolescents. Subjects were divided into two groups depending upon the rate of disease progression: adolescents with a sustained CD4%≥25 were categorized as having no immune suppression (NS), and those with CD4%≤15 categorized as having severe immune suppression (SS). We observed differences in the area of HIV-1-Gag to which the two groups made responses. In addition, subjects who expressed the HLA- B*57 or B*42 alleles were highly likely to restrict their immunodominant response through these alleles. There was a significantly higher frequency of naïve CD8+ T cells in the NS subjects (p = 0.0066) compared to the SS subjects. In contrast, there were no statistically significant differences in any other CD8+ T cell subsets. The differentiation profiles and multifunctionality of Gag-specific CD8+ T cells, regardless of immunodominance, also failed to demonstrate meaningful differences between the two groups. Together, these data suggest that, at least in vertically infected adolescents, the region of HIV-1-Gag targeted by CD8+ T cells and the magnitude of that response relative to other responses may have more importance on the rate of disease progression than their qualitative effector functions.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>21818255</pmid><doi>10.1371/journal.pone.0021135</doi><tpages>e21135</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2011-07, Vol.6 (7), p.e21135-e21135
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1306361280
source Public Library of Science (PLoS) Journals Open Access; MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Acquired immune deficiency syndrome
Adolescent
Adolescents
AIDS
Alleles
Amino Acid Sequence
Antiretroviral agents
Biology
CD4 antigen
CD8 antigen
CD8-Positive T-Lymphocytes - immunology
CD8-Positive T-Lymphocytes - pathology
CD8-Positive T-Lymphocytes - physiology
Cell Degranulation
Cell Differentiation - immunology
Children
Cohort Studies
Cytokines - metabolism
Development and progression
Disease control
Disease Progression
Drugs
Female
gag Gene Products, Human Immunodeficiency Virus - immunology
Highly active antiretroviral therapy
Histocompatibility antigen HLA
HIV
HIV Infections - immunology
HIV Infections - virology
HIV-1 - immunology
HLA antigens
HLA Antigens - immunology
Human immunodeficiency virus
Humans
Immunodominance
Immunodominant Epitopes - immunology
Immunosuppressive agents
Infectious Disease Transmission, Vertical
Lymphocytes
Lymphocytes T
Male
Medicine
Molecular Sequence Data
Pediatric diseases
Peptides
Peptides - chemistry
Peptides - immunology
Species Specificity
Statistical analysis
T cell receptors
T cells
Teenagers
Vaccines
Youth
title Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T16%3A54%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunodominance%20of%20HIV-1%20specific%20CD8+%20T-cell%20responses%20is%20related%20to%20disease%20progression%20rate%20in%20vertically%20infected%20adolescents&rft.jtitle=PloS%20one&rft.au=Sharp,%20Elizabeth%20R&rft.date=2011-07-19&rft.volume=6&rft.issue=7&rft.spage=e21135&rft.epage=e21135&rft.pages=e21135-e21135&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0021135&rft_dat=%3Cgale_plos_%3EA476884446%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1306361280&rft_id=info:pmid/21818255&rft_galeid=A476884446&rft_doaj_id=oai_doaj_org_article_678fe0ce20704414b5075c0545e92013&rfr_iscdi=true